145 related articles for article (PubMed ID: 9195539)
1. The value of biochemical markers of bone turnover in osteoporosis.
Eastell R; Blumsohn A
J Rheumatol; 1997 Jun; 24(6):1215-7. PubMed ID: 9195539
[TBL] [Abstract][Full Text] [Related]
2. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
Löfman O; Magnusson P; Toss G; Larsson L
Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
[TBL] [Abstract][Full Text] [Related]
3. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P; Delmas PD
Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
[TBL] [Abstract][Full Text] [Related]
5. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
Garnero P; Delmas PD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of bone health and osteoporosis risk.
Eastell R; Hannon RA
Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
[TBL] [Abstract][Full Text] [Related]
7. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
8. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
Bonnick SL; Shulman L
Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
[TBL] [Abstract][Full Text] [Related]
9. Osteoporosis: using 'bone markers' for diagnosis and monitoring.
Arnaud CD
Geriatrics; 1996 Apr; 51(4):24-30. PubMed ID: 8626075
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of serum and urine bone markers in the management of osteoporosis.
Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
[TBL] [Abstract][Full Text] [Related]
11. [Changes in phospho-calcium metabolic factors in function of the rate of bone turnover. Epidemiologic study of osteoporosis (part 2)].
Maini M; Brignoli E; Felicetti G; Bozzi M
Minerva Med; 1996 Dec; 87(12):565-76. PubMed ID: 9064593
[TBL] [Abstract][Full Text] [Related]
12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
13. [Biochemical markers of bone remodeling: pre-analytical variations and guidelines for their use. SFBC (Société Française de Biologie Clinique) Work Group. Biochemical markers of bone remodeling].
Garnero P; Bianchi F; Carlier MC; Genty V; Jacob N; Kamel S; Kindermans C; Plouvier E; Pressac M; Souberbielle JC
Ann Biol Clin (Paris); 2000; 58(6):683-704. PubMed ID: 11098165
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
16. [Early, noninvasive diagnostic of osteoporosis in men].
Lepiarz-Rusek W; Kokocińska D
Przegl Lek; 2005; 62(7):641-9. PubMed ID: 16463693
[TBL] [Abstract][Full Text] [Related]
17. Bone markers in osteoporosis and malignancy.
Lipton A; Costa L; Demers LM
Can J Oncol; 1995 Dec; 5 Suppl 1():11-5. PubMed ID: 8853519
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of strontium ranelate for the mineralization of bone in postmenopausal women].
Basurto L; Zárate A; Córdova N; Saucedo R; Galván R; Campos S; Hernández M
Ginecol Obstet Mex; 2009 May; 77(5):227-30. PubMed ID: 19496517
[TBL] [Abstract][Full Text] [Related]
19. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy.
Reginster JY; Collette J; Neuprez A; Zegels B; Deroisy R; Bruyere O
Bone; 2008 May; 42(5):832-6. PubMed ID: 18316258
[TBL] [Abstract][Full Text] [Related]
20. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
Midtby M; Magnus JH
Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
